A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)
| Autor: | Daugaard, G. *, Skoneczna, I., Aass, N., De Wit, R., De Santis, M., Dumez, H., Marreaud, S., Collette, L., Lluch, J.R.G., Bokemeyer, C., Schmoll, H.J. |
|---|---|
| Zdroj: | In Annals of Oncology May 2011 22(5):1054-1061 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|